Cosmelite Next Cream 30gm

Cosmelite Next Cream 30gm is used for managing hyperpigmentation, dark spots, and melasma. It is a scientifically formulated skincare product. It contains a combination of effective ingredients such as Silymarin, pTeroWhite™, Soy Extract (Isoflavones), Niacinamide, Kojic Dipalmitate, and Mandelic Acid, which work synergistically to improve skin tone and texture. This cream may help lighten discolouration, provide UV protection, and offer mild exfoliation to remove dead skin cells, revealing brighter, more even-toned skin. The formula is designed to be gentle yet effective, making it suitable for individuals dealing with melasma, dark circles, scars, and uneven skin tone. Its antioxidant-rich composition may help reduce oxidative stress on the skin, promoting a healthier complexion. Regular use, as directed, may contribute to improved skin clarity and smoothness.

• Silybum Marianum Seed Extract (Silymarin): Silymarin is an antioxidant-rich extract derived from the milk thistle plant. It helps protect the skin from oxidative stress, reduce inflammation, and support skin barrier function. Its soothing properties might also assist in calming redness and irritation, promoting an even skin tone.
   
• Pterocarpus Marsupium Bark Extract (pTeroWhite™): pTeroWhite™, derived from the bark of Pterocarpus Marsupium, is known for its skin-brightening properties. It reduces hyperpigmentation and improves skin radiance. Its antioxidant benefits might also help protect the skin from environmental damage, enhancing overall health.
   
• Glycine Soja (Soybean) Seed Extract: Soybean seed extract is a rich source of isoflavones, which may help support skin elasticity and hydration. It also reduces fine lines and improves skin texture, creating a youthful and radiant appearance.
   
• 3-O-Ethyl Ascorbic Acid: This is a stable form of Vitamin C. 3-O-Ethyl Ascorbic Acid helps brighten the skin and reduce the appearance of dark spots. It might also support collagen production, contributing to firmer and healthier skin.
   
• Kojic Dipalmitate: Kojic dipalmitate is a derivative of Kojic Acid that helps reduce melanin production. It might assist in fading dark spots and improving skin clarity, making it beneficial for individuals dealing with uneven pigmentation.
   
• Niacinamide: Niacinamide, also known as Vitamin B3, helps improve skin texture, reduce redness, and minimise the appearance of pores. It might assist in regulating sebum production and enhancing the skin barrier.
   
• Mandelic Acid: Mandelic acid is an alpha hydroxy acid (AHA) that helps with gentle exfoliation. It assists in removing dead skin cells, promoting cell turnover, and reducing pigmentation, leading to a more even skin tone.
   
• Other Ingredients: Aqua, Cetyl Alcohol, Glyceryl Stearate (and) PEG 100 Stearate, Isopropyl Palmitate, Cetearyl Alcohol (and) Ceteareth-20, Glycerin, Propylene Glycol, Sodium Polyacrylate (and) Dimethicone (and) Cyclopentasiloxane (and) Trideceth-6 (and) PEG/PPG 18/18 Dimethicone, Phenoxyethanol (and) Ethylhexylglycerin, Sodium Hydroxide, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Butyl Hydroxy Toluene, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Sodium Metabisulfite, Disodium EDTA, Fragrance.

• Manages Melasma: Cosmelite Next Cream contains active ingredients that might help manage melasma, a skin condition that leads to dark patches. It is often triggered by sun exposure or hormonal changes. The cream may assist in reducing excess melanin production, which could help improve skin tone over time. Regular use might support a more balanced and even complexion.
   
• Reduce Hyperpigmentation: The presence of Kojic Dipalmitate and pTeroWhite™ in the cream may help minimise melanin formation, which might reduce hyperpigmentation. These ingredients might contribute to a more even skin tone by lightening darker areas and reducing the appearance of discolouration. This could benefit individuals dealing with uneven skin tone or pigmentation concerns.
   
• Improve Skin Texture: This cream contains Niacinamide and Magnetic Acid, which might help refine the skin's surface, making it appear smoother and softer. These ingredients may also reduce rough patches, supporting a more even texture. The exfoliating properties of Magnetic Acid might promote skin renewal, helping to achieve a more polished and radiant look.
   
• Assist In Reducing Redness: This cream is formulated with Silymarin and Niacinamide, which may help soothe irritated skin and minimise redness. These ingredients might support skin barrier function and help calm sensitive or inflamed areas. This could benefit individuals experiencing mild skin irritation or those with reactive skin.
   
• Provide Mild Exfoliation: This cream might gently exfoliate the skin, removing dead skin cells and promoting new cell growth. This mild exfoliation may help refresh the skin's appearance and contribute to a brighter complexion. Regular use might lead to improved skin clarity and a smoother texture.
   
• Assist in Reducing Dark Circles And Scars: Combining 3-O-Ethyl Ascorbic Acid and Kojic Dipalmitate may help lighten dark circles and reduce the visibility of scars. These ingredients might also assist in evening out skin tone and reducing post-inflammatory pigmentation. The cream may support a brighter and more uniform complexion with continued use.
   
• Support Skin Hydration and Barrier Function: This cream contains Soybean Seed Extract and Niacinamide, which might help maintain skin hydration by reducing moisture loss. These ingredients may also assist in strengthening the skin barrier, improving overall skin health. Proper hydration might also enhance skin elasticity, making it feel softer and more supple.

• After cleansing the face, apply Cosmelite Next Cream on the affected areas.
• Use twice daily or as recommended by a physician.
• Gently massage until fully absorbed.

• Store in a cool, dry place away from direct sunlight.
• Keep out of reach of children.
• Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
• Not recommended for individuals below 12 years of age.